The purpose of this Funding Opportunity Announcement (FOA) is to promote collaborative biomedical research between the United States (U.S.) and Brazil under the U.S.-Brazil Collaborative Biomedical Research Program. Research areas supported under this program include allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities; neurological disorders and stroke, and environmental health sciences. This program represents an outstanding opportunity for U.S. and Brazil scientists to pursue collaborative research partnerships that address public health topics of mutual benefit to both nations.
Letter of Intent Due: Feb. 8, 2019
Deadline: March 8, 2019